WHAT IS THE MTHFR GENE — AND WHY DOES IT MATTER FOR YOUR HEALTH?

WHAT IS THE MTHFR GENE — AND WHY DOES IT MATTER FOR YOUR HEALTH?

If you've had genetic testing done — or spent any time in functional health circles — you've probably come across the term MTHFR. It's one of the most commonly discussed genetic variants in the health space, and also one of the most misunderstood.

Some corners of the internet will tell you it's a dangerous mutation that causes everything from anxiety to cancer. Others dismiss it as irrelevant. Neither is accurate. What the research actually shows is more nuanced — and more useful — than either extreme.

Here's what MTHFR actually is, what it does, and why it matters in the context of your health.

WHAT IS THE MTHFR GENE?

MTHFR stands for methylenetetrahydrofolate reductase — an enzyme your body produces to carry out a critical step in what's known as the methylation cycle. The MTHFR gene contains the instructions for making this enzyme. When there's a variation (or SNP — single nucleotide polymorphism) in this gene, the enzyme can work less efficiently than it should.

The two most clinically relevant MTHFR variants are C677T and A1298C. These are not rare — C677T in particular is found in a significant portion of the population, with homozygous variants (two copies of the altered gene) present in roughly 10–15% of people of European descent.

Having an MTHFR variant doesn't mean something is broken. It means your methylation pathway may need additional nutritional support to function at its best.

WHAT IS METHYLATION — AND WHY DOES IT MATTER?

Methylation is one of the most fundamental biochemical processes in the human body. It happens billions of times per second in every cell, and it underpins a remarkable range of functions including:

• Converting folate from food into its active, usable form (5-MTHF)
• Producing neurotransmitters including serotonin, dopamine, and noradrenaline
• Regulating gene expression — switching genes on and off
• Supporting detoxification pathways in the liver
• Producing and recycling glutathione, your body's primary antioxidant
• Regulating homocysteine — an amino acid that, when elevated, is associated with cardiovascular risk

The MTHFR enzyme sits at a critical junction in this cycle. Its job is to convert folate into its active form — 5-methyltetrahydrofolate (5-MTHF) — that the body can actually use. If MTHFR enzyme activity is reduced, this conversion step slows down. The downstream effects ripple across every process that depends on methylation working efficiently.

Think of it like a production bottleneck — if one step in the line slows down, everything that depends on it is affected.

WHAT DOES A VARIANT ACTUALLY MEAN?

The impact of an MTHFR variant depends significantly on which variant you carry and whether you have one copy (heterozygous) or two (homozygous).

The C677T variant is primarily associated with reduced folate conversion and elevated homocysteine. A homozygous C677T genotype can reduce MTHFR enzyme activity by approximately 70% — meaning the pathway is working at roughly a third of its typical capacity. A heterozygous variant results in a more moderate reduction, typically around 35–40%.

The A1298C variant affects a different part of the MTHFR enzyme and has a broader influence on a pathway called BH4 (tetrahydrobiopterin) — a critical cofactor for producing serotonin, dopamine, and nitric oxide. This makes A1298C particularly relevant when mood, stress response, and neurological symptoms are part of the picture.

Carrying both variants — one copy of each — is known as compound heterozygosity, and can have a cumulative effect on methylation capacity.

A variant is not a diagnosis. It's a piece of biological context that informs how you support your body.

WHAT ARE THE SIGNS THAT METHYLATION MAY BE SUBOPTIMAL?

Because methylation touches so many systems, the symptoms of suboptimal methylation support are varied and often non-specific — which is part of why they're frequently dismissed in a standard GP consultation. They can include:

Persistent fatigue that doesn't resolve with rest, low mood or anxiety, poor stress tolerance, brain fog or difficulty concentrating, elevated homocysteine on blood testing, poor response to standard B12 or folate supplementation, slow recovery from illness, and hormonal imbalances.

None of these symptoms are diagnostic on their own. But when they occur alongside a confirmed MTHFR variant, they provide important clinical context.

THE FOLATE PROBLEM — WHY STANDARD SUPPLEMENTS CAN BACKFIRE

This is one of the most clinically important points about MTHFR — and one that's rarely communicated clearly.

Standard folic acid (the synthetic form of folate found in most multivitamins and fortified foods) requires conversion through multiple enzymatic steps before the body can use it — including the step that MTHFR is responsible for. If your MTHFR enzyme is working at reduced capacity, folic acid supplementation may accumulate as unmetabolised folic acid rather than converting to the active form your body needs.

This is why the form of folate you supplement with matters enormously — and why two people with the same MTHFR variant can have very different responses to supplementation depending on what they're taking. There are two clinically relevant alternatives:

Methylfolate (5-MTHF) is the active, fully converted form of folate. It bypasses the MTHFR conversion step entirely, making it immediately available for use. For many people with MTHFR variants, methylfolate is highly effective at supporting the methylation pathway.

However, there is an important caveat. In some individuals — particularly those with certain compound variants or sensitivities — high-dose methylfolate can cause or worsen anxiety, irritability, insomnia, or a feeling of being "overmethylated." This is not a universal response, but it is well-documented clinically, and it's one of the key reasons MTHFR supplementation should be guided by a practitioner rather than self-prescribed based on an online result.

Folinic acid is a different form of active folate that does not require MTHFR conversion but also does not drive the methylation cycle as directly as methylfolate. For people who react poorly to methylfolate, folinic acid is often a better-tolerated alternative — it provides folate support without the risk of overstimulating the methylation pathway.

In practice, the right approach is individual. Some people do best on methylfolate alone at a carefully titrated dose. Others do better on folinic acid. And for some, a combination of both — folinic acid as the foundation with a low dose of methylfolate — provides the most balanced and well-tolerated support.

There is no universal protocol, which is precisely why knowing your full genetic and functional picture matters before supplementing.

Similarly, methylcobalamin or hydroxocobalamin are the preferred forms of B12 over cyanocobalamin — which also requires conversion steps that a compromised methylation pathway may struggle to complete efficiently.

The distinction between folic acid, folinic acid, and methylfolate is not a minor technicality. It's the difference between supplementing and actually supporting your biochemistry — and in some cases, the difference between feeling better and feeling worse.

WHAT DOES TESTING ACTUALLY TELL YOU?

Knowing you have an MTHFR variant is the starting point — not the whole picture. A variant tells you there may be a functional demand on the methylation pathway. What it doesn't tell you is how well your body is currently meeting that demand.

That's where functional testing becomes valuable. Homocysteine is the most direct functional marker of methylation — elevated levels indicate the cycle is not processing efficiently, regardless of what your MTHFR genotype shows. Active B12, RBC folate, and broader nutrient status markers give additional insight into whether the pathway has what it needs to function.

Genetic testing and functional pathology together give you the full picture — genotype tells you the risk, functional markers tell you the reality.

At Optimum Testing, our Genetic SNP Panel includes MTHFR C677T and A1298C alongside a comprehensive suite of related variants — MTR, MTRR, COMT, and others — that interact with the methylation pathway. Results are interpreted together, in the context of your individual health goal, not as isolated data points.

WHAT CAN YOU DO WITH THIS INFORMATION?

If you have an MTHFR variant, the approach is straightforward — though it should always be guided by a qualified practitioner, because the right protocol depends on which variants you carry, your current nutrient status, and your broader health picture.

Generally, supporting methylation involves ensuring adequate intake of active B vitamins in their correct forms (methylfolate or folinic acid, methylcobalamin, B6 as P5P), supporting cofactor nutrients including magnesium, zinc, and riboflavin, reducing inputs that burden the methylation pathway such as alcohol, certain medications, and chronic stress, and monitoring homocysteine as a functional marker of progress.

THE TAKEAWAY

MTHFR is neither the catastrophic mutation it's sometimes portrayed as, nor something to dismiss. It's a genetic variant that, when properly understood and supported, is entirely manageable — and for many people, understanding it is the piece of the puzzle that finally explains years of unexplained symptoms.

The goal isn't to be afraid of your genetics. It's to understand them well enough to work with them.

WANT TO KNOW YOUR MTHFR STATUS?

Our Genetic SNP Panel tests MTHFR alongside a comprehensive range of variants across methylation, mitochondrial function, detoxification, inflammation, and cardiovascular pathways. Results are interpreted by a clinical nutritionist, with a personalised protocol built around your biology and your health goal.

Explore the Genetic SNP Panel →